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Abstract
 
Class switch recombination (CSR), similar to V(D)J recombination, is thought to involve
DNA double strand breaks and repair by the nonhomologous end–joining pathway. A key
component of this pathway is DNA-dependent protein kinase (DNA-PK), consisting of a cat-
alytic subunit (DNA-PKcs) and a DNA-binding heterodimer (Ku70/80). To test whether
 
DNA-PKcs activity is essential for CSR, we examined whether IgM
 
 
 
 B cells from scid mice
with site-directed H and L chain transgenes were able to undergo CSR. Although B cells from
these mice were shown to lack DNA-PKcs activity, they were able to switch from IgM to IgG
or IgA with close to the same efficiency as B cells from control transgenic and nontransgenic
 
scid/
 
 
 
 mice, heterozygous for the 
 
scid
 
 mutation. We conclude that CSR, unlike V(D)J re-
combination, can readily occur in the absence of DNA-PKcs activity. We suggest nonhomol-
ogous end joining may not be the (primary or only) mechanism used to repair DNA breaks
during CSR.
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Introduction
 
Immunoglobulin H chain genes undergo two kinds of pro-
grammed genomic rearrangement. The first is referred to as
V(D)J recombination (1). In this process, separate and dis-
tinct gene elements (V, D, and J) are assembled into coding
segments (VDJ) for the variable regions of H chains. The
second kind of rearrangement is referred to as class switch
recombination (CSR)
 
*
 
 (2). By means of this process, a VDJ
gene segment that is initially expressed with the most up-
stream H chain constant (C) region gene (C
 
 
 
) is recom-
bined with a downstream CH gene (e.g., C
 
 
 
, C
 
 
 
, or C
 
 
 
),
resulting in the production of different Ig classes (e.g.,
IgG, IgE, or IgA). In this way, the effector function of a
given antibody molecule is changed without affecting its
antigen specificity.
CSR appears to result in DNA double strand breaks at
switch region sites targeted for recombination (3, 4). The
ends of broken DNA molecules are thought to recombine
by a nonhomologous end joining (NHEJ) mechanism (for
reviews see references 5, 6), similar to that used in the re-
pair of DNA double strand breaks resulting from the initia-
tion of V(D)J recombination or induced by ionizing radia-
tion or chemical agents (for reviews see references 7, 8).
Several proteins are known to play a critical role in NHEJ,
including DNA-PK, a multiprotein complex consisting of
a DNA-binding heterodimer, Ku70/80, and a large cata-
lytic subunit, DNA-PKcs (9–12). Results from a number of
studies suggest that DNA-PK is essential for CSR. Two
groups have shown that insertion of VDJH and VJL coding
sequences into the H and L chain loci of mice lacking
Ku70 or Ku80 (Ku70
 
 
 
/
 
 
 
 or Ku80
 
 
 
/
 
 
 
 mice) allows B cells
to develop, but these B cells are unable to undergo CSR
when stimulated in vitro with reagents that induce this
process (13, 14). Evidence for defective CSR has also been
reported for scid pre-B cells (15) that lack DNA-PKcs ac-
tivity (16, 17) and in B cells of DNA-PKcs
 
 
 
/
 
 
 
 mice with a
 
M.G. Cotticelli’s present address is Dept. of Pathology, University of
Pennsylvania Medical School, Philadelphia, PA 19104.
N.R. Ruetsch’s present address is Aventis Pharmaceuticals, Bridgewa-
ter, NJ 08807-0800.
Address correspondence to Melvin J. Bosma, Institute for Cancer
Research, Fox Chase Cancer Center, 7701 Burholme Ave., Philadel-
phia, PA 19111. Phone: 215 728-3630; Fax: 215 728-2412; E-mail:
MJ_Bosma@fccc.edu
 
*
 
Abbreviations used in this paper:
 
 A-MuLV, Abelson murine leukemia vi-
rus;
 
 
 
CSR, class switch recombination; DNA-PK, DNA-dependent pro-
tein kinase; DNA-PKcs, DNA-PK catalytic subunit; I, intronic; NHEJ,
nonhomologous end joining; RT-PCR, reverse transcriptase–PCR; S,
switch; scid, severe combined immune deficiency; sd, site-directed; tg,
transgene. 
1484
 
Ig Class Switching
 
rearranged VDJH and VJ
 
 
 
 transgene (tg; reference 18). All
of these results have been cited as evidence that the mecha-
nism of CSR is dependent on DNA-PK and involves
NHEJ. However, this inference is not without some cave-
ats. For example, B cells of Ku-deficient H/L transgenic
mice show impaired proliferation (13) and this may ac-
count, to a large extent, for the inability of these cells to
class switch. Also, B cells lacking DNA-PKcs were found
to class switch to IgG1 normally but appeared unable to
class switch to IgG2a, IgG2b, or IgG3 (18). The implica-
tion is that IgM–IgG1 switching is mechanistically distinct
from that of IgM–IgG2 or IgM–IgG3. This is difficult to
reconcile with the known structural similarity of different 
 
 
 
switch regions (19–22) and a presumed common CSR
mechanism for all isotypes.
Contrary to current thinking, we report here evidence
that DNA-PK activity is not required for CSR. We have
found that DNA-PKcs–deficient scid B cells are not only
able to class switch from IgM to IgG1, but also to IgG2a,
IgG2b, IgG3, IgA, and IgE. We used scid mice with the
VDJH and VJ
 
 
 
 coding sequence of the 3H9 (23) and V
 
 
 
8
(24) tgs, each appropriately site-directed (sd) into an H
and L(
 
 
 
) chain allele, respectively (25, 26). Although
3H9sdV
 
 
 
8sd scid mice were found to generate above nor-
mal numbers of IgM
 
 
 
 B cells, there was no evidence of
significant class switching as they lacked IgG, IgA, and IgE.
However, reconstitution of 3H9sdV
 
 
 
8sd scid mice with T
cells resulted in normal levels of serum IgG and IgA and
significant levels of IgE, indicating that the B cells in these
mice could be activated to undergo class switching in the
presence of T cells and naturally occurring antigens. To as-
sess the effect of the 
 
scid
 
 mutation on the efficiency of class
switching, splenic B cells from 3H9sdV
 
 
 
8sd scid mice and
from control transgenic and nontransgenic scid/
 
 
 
 mice
were stimulated in vitro to undergo class switching. Cell
cultures were tested for all of the following: (1) transcripts
resulting from recombination between the 
 
 
 
 and 
 
 
 
1, 
 
 
 
2b,
 
 
 
3, and 
 
 
 
 switch regions; (2) frequency of IgG1
 
 
 
, IgG2b
 
 
 
,
IgG3
 
 
 
, and IgA
 
 
 
 cells; and (3) for levels of the corre-
sponding isotypes, including IgE, in the culture medium.
Our overall results indicate that the efficiency of class
switching in scid transgenic B cells is close to that of con-
trol scid/
 
 
 
 B cells.
 
Materials and Methods
 
Mice.
 
 C.B-17 scid mice (scid mice) with the VDJH and VJ
 
 
 
coding sequence of the 3H9 (23) and V
 
 
 
8 (24) tgs appropriately
inserted into an H and L(
 
 
 
) allele, respectively, were obtained by
selective crossing of these tgs into the scid genetic background us-
ing previously established lines of 3H9sd and V
 
 
 
8sd BALB/c
mice (25, 26). Mice heterozygous for the 
 
scid
 
 mutation (scid/
 
 
 
)
and bearing the 3H9sd tg and the nonsd V
 
 
 
8 tg (24) were used as
transgenic controls. We also used nontransgenic scid/
 
 
 
 mice as
an additional control. All H/L chain transgenic scid and scid/
 
 
 
mice used in this work were hemizygous for their tgs and can be
formally designated as 3H9sd/
 
 
 
, V
 
 
 
8sd/
 
 
 
, scid/scid mice and
3H9sd/
 
 
 
, V
 
 
 
8/
 
 
 
, scid/
 
 
 
 mice. We will simply refer to these
 
mice as 3H9sdV
 
 
 
8sd scid and 3H9sdV
 
 
 
8 scid/
 
 
 
 mice. In some
experiments, 3H9sdV
 
 
 
8sd scid mice were intravenously injected
with a suspension of bone marrow cells and thymocytes (or thy-
mocytes alone) from mice with deleted JH loci (JH
 
 
 
/
 
 
 
; reference
27). The strain background of the JH
 
 
 
/
 
 
 
 mice used was BALB/c.
These mice, here simply referred to as JH
 
 
 
/
 
 
 
 mice, were ob-
tained from Taconic. The absence of detectable B cells and serum
Ig in JH
 
 
 
/
 
 
 
 mice was confirmed by flow cytometry and ELISA,
respectively. Mice with disrupted DNA-PKcs alleles (DNA-PK
 
 
 
/
 
 
 
mice; reference 28) were provided by G. Taccioli, Boston Uni-
versity School of Medicine, Boston, MA. All mice used in this
work were between 9 and 17 wk of age and were maintained as
specific pathogen-free mice in the Laboratory Animal Facility of
the Fox Chase Cancer Center.
 
Cells.  
 
Spleen cell suspensions were treated with 0.165 M
NH
 
4
 
Cl-Tris to eliminate erythrocytes, washed, passed through a
Nytex sterile nylon screen (Tetko), and resuspended in culture
medium (RPMI-1640 containing 10% FCS, 5 
 
 
 
 10
 
 
 
5 
 
M 2ME, 2
mM glutamine, and 10 mM Hepes and gentamycin at 50 
 
 
 
g/ml).
For isotype switch analysis, spleen cells were cultured for 2 or 4 d
in culture medium containing 50 
 
 
 
g/ml 
 
Salmonella typhimurium
 
LPS (Sigma-Aldrich) with or without IL4 (50 or 100 ng/ml) or 1
ng/ml TGF
 
 
 
 (R & D Systems). Cells were deposited in 6-well
plates at cell concentrations of 0.25 
 
 
 
 10
 
6
 
 or 0.75 
 
 
 
 10
 
6
 
 cells/ml.
Bone marrow and thymus cell suspensions from JH
 
 
 
/
 
 
 
 mice were
prepared in the manner described previously (29).
 
Flow Cytometry.  
 
Cells were stained for the B cell marker,
CD45(B220), using anti-B220 (RA3–6B2) conjugated with allo-
phycocyanin (30) and for surface IgM, IgG1, IgG2b, IgG3, or
IgA using FITC-conjugated anti-IgM (331.1), anti-IgG1 (A85.1),
anti-IgG2b (R12–3), anti-IgG3 (R40–82), or anti-IgA (C10–3)
(BD PharMingen). The staining of cells was performed as de-
scribed by Hardy (31). In some experiments, cells were stained
for B220 and CD3, using anti-CD3 (500A2) conjugated with
phycoerythrin (BD PharMingen). B220
 
 
 
IgG
 
 
 
, B220
 
 
 
IgA
 
 
 
, and
B220
 
 
 
CD3
 
 
 
 cells were enumerated by multiparameter flow cy-
tometry using a FACS
 
®
 
 VantageSE flow cytometer (Becton
Dickinson). To enrich for splenic B cells, we stained cells with al-
lophycocyanin-conjugated anti-B220 and then sorted for B220
 
 
 
cells using the FACS
 
®
 
 VantageSE. Forward and light-angle scat-
ter gates were set to exclude nonlymphoid cells. Dead cells were
identified by propidium iodide staining and excluded from analy-
sis. All analyses of flow cytometric data were performed using the
FlowJo software package (TreeStar).
 
 Reverse Transcriptase–PCR. 
 
Total RNA and cDNA were
prepared from 2-d spleen cell cultures by applying the methodol-
ogy described by Kinoshita et al. (32). Briefly, total RNA was ex-
tracted using TRIzol (Invitrogen) according to manufacturer’s in-
structions, and cDNA was synthesized with Superscript II
(Invitrogen) using 2 
 
 
 
g of total RNA and 1 
 
 
 
g of Oligo(dT)12–
18 Primer (Invitrogen) in a 20-
 
 
 
l reaction volume (one twenti-
eth of which served as a template for subsequent RT-PCR am-
plification in a 25-
 
 
 
l reaction volume). Post-switch transcripts of
different intronic (I) exons spliced to the 5
 
 
 
 C
 
 
 
 exon, represent-
ing the excised circular DNA of different switching events, were
PCR-amplified with the oligonucleotide primers described by
Kinoshita et al. (32) using the following modified conditions: 33
cycles of PCR were used to amplify I
 
 
 
1-C
 
 
 
 transcripts; I
 
 
 
2b-C
 
 
 
and I
 
 
 
3-C
 
 
 
 transcripts were amplified after an initial dena-
turing step of 95
 
 
 
C for 6 min followed by 35 cycles of PCR
(94
 
 
 
C for 30 s, 58
 
 
 
C for 1 min) using Faststart Taq DNA poly-
merase (Roche) with 5
 
 
 
 G-C rich solution in the presence of
2.5 mM Mg
 
2
 
 . I promoter–generated transcripts representing1485 Bosma et al.
nonexcised rearranged DNA of a class switch event (I -CH tran-
scripts) were amplified using the oligonucleotide primer pairs
used by Muramatsu et al. (33) with the following PCR condi-
tions: I -C 3 transcripts were amplified after an initial denatur-
ing step of 95 C for 9 min followed by 30 cycles of PCR (94 C
for 30 s, 58 C for 1 min) by using AmpliTaq Gold (Perkin-
Elmer) in the presence of 2.5 mM Mg2 ; and for I -C , I -
C 1, and I -C 2b transcripts, an initial denaturing step of 95 C
for 5 min followed by 30 cycles of PCR (95 C for 30 s, 58 C for
30 s, 72 C for 40 s) using Faststart Taq DNA polymerase (Roche)
in the presence of 2.5 mM Mg2 .  2-microglobulin ( 2M) prim-
ers (MB522, 5 -GAATGGGAAGCCGAACATACTGAACTG-
3 ; MB523, 5 -TGCTGATCACATGTCTCGATCC-3 ) were
used to amplify  2M transcripts (255 bp) to serve as an internal
control for input cDNA. Conditions for  2M transcript amplifi-
cation were as follows: an initial denaturing step of 95 C for 9
min followed by 20 cycles of PCR (94 C for 30 s, 58 C for 1
min) using AmpliTaq Gold (Perkin-Elmer) in the presence of 2.5
mM Mg2 . All PCR reactions were run on a programmable ther-
mal control machine (model PTC-100; MJ Research, Inc.).
Southern Blot Analysis. RT-PCR–amplified products were
separated by electrophoresis in agarose gels (1.6%), transferred to
Nytran Supercharge nylon transfer membrane (Schleicher &
Schuell) and detected by  -32P-labeled oligonucleotide probes.
(In some experiments [see Fig. 4], the  2M transcripts were visu-
alized by ethidium bromide staining of the gel.) The oligonucle-
otide probes for circle transcripts, C P (32), I -CH transcripts,
(MB554, 5 -AATGTATGGTTGTGGCTTCTGCCACCCAT
CC-3 , nucleotides 4067–4098 of the I  region; GenBank acces-
sion no., J00440), and  2M transcripts (MB522) were labeled us-
ing a T4 Polynucleotide Kinase Kit (Invitrogen). All blots were
prehybridized in a solution of 6 SSC, 0.1% SDS, 5  Denhardt’s
solution, and 100  g/ml salmon sperm DNA at 60 C (58 C for
 2M) for 5 h; hybridized overnight (12–15 h) at 60 C (58 C for
 2M) in a solution of 6 SSC, 0.75% SDS, 5  Denhardt’s solution,
and 100  g/ml salmon sperm DNA; and washed in a solution of 5 
SSC and 0.1% SDS three times for 5 min at room temperature
and one time for 5 min at 60 C (58 C for  2M). The membranes
were exposed to a PhosphorImaging plate for quantification of
bound  -32P-labeled probes using a FujiX-BioImaging Analyzer.
DNA-PKcs Activity. Early B lineage cells from fetal liver and/
or adult bone marrow of scid, scid/ , and DNA-PKcs / 
mice were transformed by the Abelson murine leukemia virus
(A-MuLV), as described previously (34). Nuclear extracts from
A-MuLV–transformed cells (20   106 cells), LPS/IL4-stimulated
splenic B cells (20   106 cells), and HeLa cells (5   106 cells)
were prepared using the Dignam method as modified by An-
drews and Faller (35). Extracts were diluted 1:1 in buffer and in-
cubated with preswollen DNA–cellulose beads (Sigma-Aldrich)
to bind Ku and DNA-PKcs, as described by Woo et al. (36). To
test for DNA-PKcs activity, we used the SignaTECT DNA-PK
assay kit (Promega) in accordance with the manufacturer’s in-
structions. Briefly, after the beads were incubated with nuclear
extract, they were washed and resuspended in dilution buffer (12
 l) along with enzyme substrate (biotinylated p53 peptide) and
 -[32P]ATP. After a 5-min incubation, the kinase reaction was
terminated and reaction mixtures were spotted onto prenum-
bered squares of a streptavidin-coated membrane. The mem-
brane was washed and exposed to a PhosphorImaging plate for
quantitation of bound  -32P-labeled peptide using a FujiX-Bio
Imaging Analyzer.
Serological Assays. Mouse sera and supernatants of LPS/IL4-
stimulated cell cultures were assayed for secreted IgE by ELISA
using an OptEIA mouse IgE kit as directed by the manufacturer
(BD PharMingen). ELISA was also used to measure the concen-
trations of IgM, IgG1, IgG2a, IgG2b, IgG3, and IgA in mouse
sera or tissue culture media. For this, we used the same buffers
and solutions as described in the above mouse IgE kit and puri-
fied mAbs specific for IgM, IgG1, IgG2a, IgG2b, IgG3, or IgA
(BD PharMingen). The ELISA protocol in all experiments was as
follows: the wells of 96-well plates (Nunc-Immuno™ plates)
were coated with a given mAb (capture antibody), washed, and
blocked with PBS containing 10% FCS. Serial dilutions of
mouse sera or tissue culture media were added to the wells, and
after a 2-h incubation and subsequent washing of the wells, a bio-
tinylated version of the capture antibody (referred to as the de-
tection antibody) was added together with avidin–horseradish
peroxidase conjugate. After a 30-min incubation, the wells were
washed and substrate (tetramethylbenzidine and hydrogen perox-
ide) was added. 30 min later, the optical density readings were
taken at 450 nm using a Multiskan Ascent reader (Thermo Lab-
systems). Readings were compared with a standard curve of opti-
cal densities obtained by using serial dilutions of the appropriate
affinity-purified mouse Ig (IgM, IgG1, IgG2a, IgG2b, IgG3, IgA,
or IgE).
Results
Effect of scid Mutation on Ig Class Switching In Vivo.
Given the earlier findings of Xu et al. (37), indicating the
presence of partially activated B cells in T cell–deficient
3H9sdV 8 RAG /  mice, it seemed likely that a similar B
cell population might be present in T cell–deficient
3H9sdV 8sd scid mice, and that this B cell population
might be stimulated to differentiate and undergo class
switching in the presence of T cells. Therefore, 3H9sd-
V 8sd scid mice were injected intravenously with a mix-
ture of bone marrow (3.0   106 cells) and thymocytes (2.0  
106 cells) from JH /  mice to provide a source of T cells in
the absence of contaminating donor B cells. Results for one
of three such experiments are illustrated in Figs. 1 B and 2.
At 5 wk after injection, 3H9sdV 8sd scid recipients were
found to contain splenic T cells (Fig. 1 B), and normal to
above normal concentrations of serum IgG and IgA and
significant concentrations of IgE (Fig. 2). Note that IgE
concentrations in T cell–reconstituted 3H9sdV 8sd scid
mice were highly variable and ranged from 43 to 2,741 ng/
ml; IgE concentrations in four age-matched scid/  con-
trols were somewhat higher and less variable. Before injec-
tion, 3H9sdV 8sd scid mice contained  10  g/ml of IgG
and IgA and  20 ng/ml of IgE (Fig. 2), despite having
above normal numbers of B220 IgM  splenic B cells (Fig.
1 A and Table I). Most 3H9sdV 8sd scid mice also lacked
IgM ( 10  g/ml; unpublished data). As discussed later, the
lack of serum Ig in 3H9sdV 8sd scid mice is consistent
with previous reports indicating that B cells expressing the
3H9V 8 antibody are inactive when these cells arise in
nonautoimmune strains of mice, such as BALB/c or
C.B-17 (23, 37, 38).
As indicated in Table II, half of the 3H9sdV 8sd scid re-
cipients depicted in Fig. 2 contained above normal concen-
trations of all four IgG isotypes (IgG1, IgG2a, IgG2b, and1486 Ig Class Switching
IgG3); the remaining half showed marked imbalances in
isotype representation, possibly reflecting a low multiplicity
of IgG-producing clones. All of the recipients contained
IgG of the tg allotype (IgGa), and none were found to con-
tain IgG of the endogenous (C.B-17) allotype (IgGb; un-
published data), which is consistent with the known ability
of the tgs to inhibit endogenous H (and L) chain gene rear-
rangement (23, 30) and the severe impairment of VH-DJH
rearrangement in scid mice (39). We interpret the results of
Table II and Figs. 1 B and 2 to indicate that IgM  trans-
Figure 1. Flow cytometric
analysis of 3H9sdVk8sd scid
spleen for B and T cells. (A).
Contour plots show B220 ver-
sus IgM staining on spleen cells
from two 3H9sdV 8sd scid mice
and from a nontransgenic scid/ 
and scid mouse. The numbers
below the small boxes corre-
spond to the percentage of
B220 IgM  cells. (B). Contour
plots show B220 versus CD3
staining of spleen cells from two
3H9sdV 8sd scid mice and from
two 3H9sdV 8sd scid mice that
were injected 5 wk earlier with a
mixture of 3.0   106 bone mar-
row cells and 2.0   106 thy-
mocytes from JH /  mice
(3H9sdV 8sd scid   T). The
numbers above the small boxes
correspond to the percentage of
B220 CD3  cells.
Figure 2. Induction of IgG, IgA, and IgE production in 3H9sdVk8sd
scid mice reconstituted with T cells. 3H9sdV 8sd scid mice were injected
intravenously with a mixture of 3   106 bone marrow cells and 2   106
thymocytes from JH /  donor mice. The concentration of total IgG ( g/
ml) in each of eight individual 3H9sdV 8sd scid recipients is indicated at
day 1, and week 2, 4, and 5 after cell injection. IgA concentrations are
shown for week 4 and 5; no IgA ( 10  g/ml) was detectable at day 1 and
14 after cell injection. The small inserted graph shows the serum IgE con-
centrations (ng/ml) in the eight 3H9sdV 8sd scid mice before and after
being injected with 3   106 bone marrow cells and 2   106 thymocytes
from JH /  donor mice. Normal concentrations of IgG, IgA and IgE in
individual C.B-17 scid/  mice are indicated with closed triangles. Flow
cytometry was used to confirm that 3H9sdV 8sd scid recipients contained
T cells (Fig. 1 B) and that the JH /  donor mice lacked B cells (not de-
picted). Similar results to those shown were obtained when 3H9sdV 8sd
scid mice were injected with 5   106 JH /  thymocytes alone.
Table I. Spleen Cellularity and Percentage of Splenic B Cells in
scid (s/s), scid/  (s/ ), 3H9sdV 8sd s/s, and 3H9sdV 8 
s/  Micea
Genotype
No. of
mice
No. of spleen
cells   10 6
Percent B220 IgM 
spleen cells
s/s  6  3.5   3.3  0.5
3H9sdV 8sd s/s 12 89   14 83   11
3H9sdV 8 s/   6 39   8 34   3 
s/   9 107   30 49   10
aCell counts were made in a hemacytometer, and the number of viable
cells were scored on the basis of their ability to exclude trypan blue.
The values shown represent the mean number ( SEM) of spleen cells
and mean percentage ( SEM) of B cells for the indicated number of
mice analyzed. The percentage of B220 IgM  cells was determined by
flow cytometry (Materials and Methods).
Table II.  Concentration of IgG1, IgG2a, IgG2b, IgG3 and 
Total IgG in Serum of T Cell-reconstituted 3H9sdV 8sd scid Micea
Mouse IgG1 IgG2a IgG2b IgG3 Total IgG
 g/ml  g/ml  g/ml  g/ml  g/ml
26 489 474 915 617 2,495
30 670 133 317 664 1,784
29 531 107 234 839 1,711
27 634 128 146 424 1,332
31 585  42  34 695 1,356
28 314 439  29 106 888
33 350  16 306  42 714
32 360  62  2 124 547
aIgG isotype concentrations correspond to those in the sera of
3H9sdV 8sd scid mice 35 d after being injected with lymphoid cells
from JH /  donors. The eight 3H9sdV 8sd scid recipients are the same
as those analyzed in Fig. 2. It should be noted that the serum IgG1 con-
centrations shown are comparable to what we find in specific patho-
gen-free C.B-17 wt mice (555   291  g/ml). However, the indicated
concentrations of IgG2a, IgG2b, and IgG3 are (in most cases) much
higher than those of serum IgG2a (4.7   2.3  g/ml), IgG2b (25   12
 g/ml), and IgG3 (53   11  g/ml) in specific pathogen-free C.B-17
wt mice. 1487 Bosma et al.
genic B cells in 3H9sdV 8sd scid mice can be readily acti-
vated in the presence of T cells and naturally occurring an-
tigen to differentiate and class switch to different Ig
isotypes. Thus, we see no evidence for a severe impairment
of Ig class switching in scid B cells using a biologically rele-
vant system.
Effect of scid Mutation on Ig Class Switching In Vitro. The
relative efficiency of class switching in 3H9sdV 8sd scid
mice could not be inferred from the preceding results be-
cause there is no normal control in these experiments.
Moreover, even in a biologically relevant system such as
3H9sdV 8sd scid mice, strong antigenic selection of trans-
genic B cells (or other complex variables) could potentially
mask a significant impairment of class switching. Therefore,
we compared the ability of 3H9sdV 8sd scid B cells to un-
dergo class switching in vitro relative to B cells of control
transgenic and nontransgenic scid/  mice.
Molecular Analysis.  To assess the relative efficiency
with which scid B cells initiate and complete CSR, splenic
B cells of 3H9sdV 8sd scid, 3H9sdV 8 scid/ , and non-
transgenic scid/  mice were stimulated with B cell mito-
gen (LPS) and cytokine (IL4 or TGF ) or with LPS alone.
Cell cultures were then analyzed 2 d later for the presence
of I promoter–generated transcripts (40) resulting from re-
combination between the   and  3,  1,  2b, or   switch
regions. The transcripts were detected by RT-PCR using
the protocol described previously (32, 33). Post-switch
transcripts from both nonexcised and excised rearranged
DNA were amplified (Fig. 3); i.e., those generated from
the I  promoter spliced to the 5  exon of a rearranged CH
gene (e.g., I -C 3 transcripts) and those generated from
the I promoter of a rearranged CH gene spliced to the 5 
exon of the C  gene (e.g., I 3-C  transcripts). The latter
transcripts are referred to as circle transcripts because they
derive from excised circular DNA (32).
As shown in Fig. 4, I 3-C , I 1-C , I 2b-C , and I -
C  circle transcripts were detected in LPS-stimulated
3H9sdV 8sd scid and scid/  control spleen cells, cultured
with the appropriate cytokine. Importantly, circle tran-
scripts were not detectable in ex vivo (nonstimulated)
3H9sdV 8sd scid spleen cells. Thus, the observed circle
transcripts reflect recombination events initiated in vitro. In
Fig. 5, we show titration results for PCR amplification of
post-switch transcripts in serially diluted cDNA from
3H9sdV 8sd scid and 3H9sdV 8 scid/  cells stimulated
with LPS, LPS/IL4, or LPS/TGF . The intensity of hy-
bridizing signal associated with post-switch transcripts from
both excised and nonexcised rearranged DNA correlated
with the amount of input cDNA in the internal control
( 2M). Quantitation of the amount of  -32P-labeled probe
hybridizing to a given post-switch transcript, normalized
against the internal control, showed the abundance of post-
switch transcripts in 3H9sdV 8sd scid to be comparable
to (or approximately two- to threefold less than) the
3H9sdV 8 scid/  cell controls, depending on the particu-
lar transcripts being assayed (Fig. 5 legend). Allowing for a
twofold greater frequency of B cells in 3H9sdV 8sd scid
than in 3H9sdV 8 scid/  at the start of culture (Table I),
we conclude from these results that the efficiency of class
switching in scid transgenic B cells is within two to fivefold
of that in scid/  transgenic B cells.
Cellular Analysis.  To evaluate the effect of the scid mu-
tation on the generation of IgG- and IgA-expressing B cells
in vitro, spleen cells from individual 3H9sdV 8sd scid,
3H9sdV 8 scid/ , and nontransgenic scid/  mice were
separately stimulated in parallel with LPS and LPS/IL4 or
with LPS and LPS/TGF . To compensate for the high
percentage of B cells in 3H9sdV 8sd scid spleen (Table I),
3H9sdV 8 scid/  and nontransgenic scid/  control cell
cultures were initiated with FACS®-sorted B220  splenic
cells. Alternatively, 3H9sdV 8sd scid spleen cells were
mixed with an equal number of spleen cells from JH / 
mice so that scid cell cultures were initiated with a similar
Figure 3. Illustration of intronic (I) promoter–generated transcripts
associated with Ig class switching. Cartoon depicts targeting of   and  3
switch (S) regions for recombination, intermediate products (within
brackets) and recombined products with the two types of I-generated
post-switch transcripts: I -C 3 and I 3-C  (circle) transcripts (see Re-
sults for further details).
Figure 4. Detection of I pro-
moter–generated post-switch
(circle) transcripts in stimulated
3H9sdVk8sd scid spleen cells.
PCR-amplified I 3-C , I 1-
C , I 2b-C , and I -C  tran-
scripts in cDNA from 2-d cell
cultures stimulated with LPS,
LPS/IL4, and LPS/TGF , re-
spectively, were readily detect-
able by Southern blot analysis of
gel-separated PCR products.
The transcripts are seen in the
plus ( ) lane for each genotype
of mouse tested: nontransgenic
scid/  (s/ ), 3H9sdV 8 scid/ 
(tg s/ ), and 3H9sdV 8sd scid
(tg s/s). Post-switch circle transcripts were not detectable in nonstimu-
lated cells taken directly from the animal (minus [ ] lanes; except for the
barely detectable I 3-C  transcripts in the s/  controls).  2M, visual-
ized by ethidium bromide staining of the gel, served as an internal control
for cDNA input.1488 Ig Class Switching
number of splenic B cells as control scid/  cell cultures.
Cell cultures were analyzed at day 4 by flow cytometry for
Ig surface–positive (Ig ) B cells of different isotypes. Gates
were set to include only brightly stained B220 Ig  cells.
As illustrated in Fig. 6 A, 4-d cultures of 3H9sdV 8sd
scid spleen cells stimulated with LPS generally showed
only a two- to threefold lower percentage ( 0.65%) of
B220 IgG3  cells than control 3H9sdV 8 scid/  (1.2%)
and nontransgenic scid/  (2%) cell cultures initiated with
sorted B220  splenic cells. When 3H9sdV 8sd scid spleen
cells and 3H9sdV 8 scid/  sorted B220  splenic cells
were stimulated with LPS/IL4, we found 4-d cultures to
contain comparable percentages of B220 IgG1  cells (8–
10%; Fig. 6 A) as opposed to  0.12% of IgG1-expressing
cells in cultures stimulated with LPS alone (unpublished
data). Nontransgenic scid/  controls stimulated with LPS/
IL4 generally contained 12–18% B220 IgG1  cells. In cul-
tures of 3H9sdV 8sd scid spleen cells stimulated with LPS/
TGF , we detected IgG2b  and IgA  cells. The frequency
of IgG2b  scid cells ( 1.5%) was within twofold that of
the 3H9sdV 8 scid/  control (2.3%), as illustrated in Fig.
6 B. The nontransgenic scid/  control in this experiment
showed an unusually low percentage of IgG2b  cells. LPS/
TGF -stimulated cultures of 3H9sdV 8sd scid spleen cells
also contained B220 IgA  cells at a frequency within
threefold of that in the 3H9sdV 8 scid/  controls (Fig. 6
B, bottom row). Although the frequency of B220 IgA 
cells was extremely low ( 0.2–0.4%), no B220 IgA  cells
( 0.02%) were detected in scid or scid/  cell cultures
stimulated with LPS alone (unpublished data).
To compare the extent of cell proliferation in
3H9sdV 8sd scid and control cell cultures, cell counts were
made at day 1, 2, 3 and 4 of culture. Viability remained
high ( 90%) for all cell cultures at day 1, 2, and 3 (unpub-
lished data) and then dropped below 80% at day 4 with scid
cultures often showing somewhat lower viability than the
controls. As illustrated in Table III for LPS/IL4-stimulated
B cells, cell viability was generally 65–75% at day 4 with
Figure 5. Relative abundance of I promoter–generated post-switch
transcripts in stimulated 3H9sdV 8sd scid and 3H9sdV 8 scid/  spleen
cells. Post-switch transcripts of excised (e.g., I 3-C ) and nonexcised
(e.g., I -C 3) rearranged DNA were PCR amplified from threefold se-
rial dilutions of cDNA obtained from 3H9sdV 8sd scid (tg s/s) and
3H9sdV 8 scid/  (tg s/ ) control cells stimulated for 2 d with LPS,
LPS/IL4, or LPS/TGF . Post-switch transcripts and those of the internal
control ( 2M) were detected by Southern blot analysis of gel-separated
PCR products. PhosphorImaging of the transfer membrane (Materials
and Methods) showed the relative amount of a given post-switch tran-
script at each serial dilution to be proportional to the amount of  2M
transcript, the control for amount of input cDNA. The ratio of the
amount of probe hybridizing to a given post-switch transcript/ 2M tran-
script in 3H9sdV 8sd scid cells divided by that of the 3H9sdV 8 scid/ 
control gave the following mean values: 2.2, 0.47, and 2.1 for I 3-C ,
I 1-C , and I 2b-C  circle transcripts (I -C  circle transcripts were
not titrated); and 0.56, 0.89, 0.36, and 0.31 for I -C 3, I -C 1, I -
C 2b, and I -C  transcripts, respectively.
Figure 6. Generation of IgG- and IgA-expressing B cells in cultures of
3H9sdV 8sd scid spleen cells. (A) Spleen cells (0.5   106 cells) from two
individual 3H9sdV 8sd scid (tg s/s) mice and sorted B220  splenic cells
from a 3H9sdV 8 scid/  (tg s/ ) and nontg scid/  (s/ ) control mouse
were each plated separately at 0.25   106 cells/ml in 6-well plates in the
presence of LPS or LPS/IL4. After 4 d, each cell culture was analyzed by
flow cytometry for the presence of B220 IgG3  and B220 IgG1  cells,
respectively. The numbers at the bottom of the small boxes correspond to
the percentage of IgG3  or IgG1  cells. (B) Spleen cells from two indi-
vidual 3H9sdV 8sd scid (tg s/s) mice were each mixed with an equal
number of JH /  spleen cells and plated separately at a total cell concen-
tration of 0.75   106 cells/ml to give the same approximate number of B
cells as plated in the tg s/  and s/  control cell cultures, containing
0.75   106 spleen cells/ml (based on results of Table I). Cells were cul-
tured in the presence of LPS/TGF  for 4 d, and then each cell culture
was analyzed by flow cytometry for the presence of B220 IgG2b  and
B220 IgA  cells. The numbers at the bottom of the small boxes corre-
spond to the percentage of IgG2b  or IgA  cells. The results shown in A
and B are representative of four independent experiments. Data are dis-
played as pseudo-color plots printed in black and white.1489 Bosma et al.
most cultures showing a four- to eightfold increase in cell
concentration. Note that the scid cell cultures in experi-
ment A showed a lower percentage of viable cells than the
scid/  controls but still contained as many viable cells as
the controls. Thus, in this experiment, the scid cells appear
to have proliferated to a greater extent than the scid/ 
controls. Note also that in each experiment, the level of se-
creted IgG1 in the culture medium correlated with the
yield of IgG1  cells. We also tested for the presence of se-
creted IgE because the concentration of IL4 used in these
experiments was sufficiently high (100 ng/ml) to expect
some class switching to IgE (41, 42). As shown in Table III,
low levels of IgE were detectable in three of four scid/ 
cell cultures but not in any of the scid cell cultures.
Serological Analysis.  To test for serologic evidence of
impaired Ig class switching, we compared the kinetics of Ig
production (secretion) in spleen cell cultures of appropri-
ately stimulated 3H9sdV 8sd scid and 3H9sdV 8 scid/ 
cells. As illustrated in Fig. 7, the concentration of IgG1 in
culture supernatants of LPS/IL4-stimulated scid cells in-
creased between day 3 and 5 from  20 to a range of 70–
215 ng/ml. In the scid/  control cell cultures, there was a
greater increase of IgG1, from  20 to a range of 400–500
ng/ml. Supernatants from the same cell cultures were also
tested for IgE. As indicated, IgE was not detectable in the
scid cell cultures, but low amounts of IgE (15–25 ng/ml)
were detectable in the scid/  control cultures. In both
LPS-stimulated scid and scid/  control cell cultures, IgG2a
concentrations increased from  5 ng/ml at day 3 to a
range of 65–72 ng/ml at day 4 and appeared to plateau in
the range of 72–111 ng/ml at day 5 (Fig. 7). Secreted IgG3
also increased dramatically between day 3 and 5 (from  5
to  200 ng/ml) with similar kinetics in scid and scid/ 
cell cultures. In cultures of LPS/TGF -stimulated cells,
IgG2b concentrations rose rapidly between day 3 and 5
(from  10 to  300 ng/ml), and again, with similar kinet-
ics in both scid and scid/  control cultures (Fig. 7). Secreted
IgA was not detectable ( 5 ng/ml) in LPS/TGF -stimu-
lated cell cultures (unpublished data), which is consistent
with a very low frequency of IgA  cells (Fig. 6 B).
The results of Fig. 7 are consistent with those of Figs. 5
and 6, and indicate that the scid mutation has little or no
discernible effect on IgM–IgG class switching. Whether
switching to IgE is also relatively unimpaired in scid B cells
is unclear from the above results, because IgE was not de-
tected in supernatants of the LPS/IL4-stimulated scid cell
cultures and was just barely detectable in the scid/  con-
trols ( 25 ng/ml).
Absence of DNA-PKcs Activity in scid B Lineage Cells.  Pre-
vious reports have indicated that most scid cell lines contain
little or no detectable DNA-PKcs protein (43–45). How-
ever, some scid cell lines, such as bcl-2 scid pre-B cell lines,
have been reported to contain near normal amounts of
DNA-PKcs protein, although no DNA-PKcs activity was
detectable in whole cell extracts from these lines (16, 17).
To confirm that DNA-PKcs activity is indeed absent in the
Table III. Yield of Viable Cells, IgG  Cells, and Secreted IgG1 
(and IgE) in 4-d Cultures of LPS/IL4-stimulated B Cellsa
Exp Genotype
Percent
viability
Cells/ml
  10 6
Percent
IgG  cells [IgG1] [IgE]
ng/ml ng/ml
As /   73 2.2 18.0 242 8
tg s/  76 2.2 10.1 85  1
tg s/s 58 2.1 9.2 97  1
tg s/s 52 2.5 10.0 108  1
Bs /   77 1.8 12.6 723 48
tg s/  68 1.7 10.2 587 20
tg s/s 78 1.1 7.7 312  1
tg s/s 62 1.8 8.9 305  1
aSpleen cells from individual 3H9sdVk8sd scid mice (tg s/s) and sorted
B220  splenic cells from a 3H9sdV 8 scid/  (tg s/ ) and nontrans-
genic scid/  (s/ ) control mouse were plated at 0.25   106 cells/ml.
The source of cells for each genotype shown was an individual mouse.
(A and B represent additional, independent experiments to those de-
scribed in Fig. 7 A). Cell counts were made as described in Table I.
The percentage of IgG1  cells and levels of secreted IgG1 and IgE
were ascertained by flow cytometry and ELISA, respectively (Materials
and Methods).
Figure 7. Concentration of secreted IgG1 (and IgE), IgG3, IgG2a, and
IgG2b in 3-, 4- and 5-d cultures of stimulated 3H9sdV 8sd scid and
3H9sdV 8 scid/  spleen cells. Spleen cells from individual 3H9sdV 8sd
scid and 3H9sdV 8 scid/  control mice were stimulated separately with
LPS/IL4, LPS/TGF , and LPS alone, and then cell culture supernatants
were tested for concentrations of secreted IgG1/IgE, IgG2b/IgA, and
IgG2a/IgG3, respectively. The points (diamonds for 3H9sdV 8sd scid and
squares for 3H9sdV 8 scid/  controls) represent the concentrations of a
given isotype in individual cell cultures (each culture corresponding to an
individual mouse). Points on the abscissa correspond to  1 ng/ml. Cul-
ture conditions and starting cell concentrations were as described in Fig. 6 B.1490 Ig Class Switching
nucleus of scid B lineage cells, we first tested for the pres-
ence of such activity in nuclear extracts of A-MuLV–trans-
formed scid pre-B cells. As shown in Table IV A, the
amount of DNA-PKcs activity in pre-B cell lines derived
from scid adult bone marrow and scid fetal liver was equiv-
alent to that in pre-B cell lines from the bone marrow of
DNA-PKcs /  mice. Nuclear extracts of A-MuLV–trans-
formed pre-B cells from wt mice and the human HeLa cell
line served as positive controls. Note that the DNA-PKcs
activity in the HeLa cell line was 15–17-fold greater than
that in the pre-B cell lines from wt mice. This magnitude
of difference in DNA-PKcs activity between mouse and
human cell lines is consistent with previous reports (45,
46). We also tested nuclear extracts of LPS/IL4-stimulated
3H9sdV 8sd scid B cells for DNA-PKcs activity. A suspen-
sion of 107 cells from two 3H9sdV 8sd scid mice, consist-
ing of 77% B220 IgM  B cells, was aliquoted into 6-well
plates at 0.25   106 cells/ml. The cells were cultured for
3 d in the presence of LPS and IL4. An equivalent number
of sorted B220  splenic cells from 3H9sdV 8 scid/  mice
(controls) was cultured in parallel under the same condi-
tions. At day 3, cells from the scid and scid/  cultures
were separately pooled and analyzed for DNA-PKcs activ-
ity. As indicated in Table IV B, there was no apparent
DNA-PKcs activity in the cultured scid cells relative to that
of the negative controls (DNA-PK /  cells), though such
activity was clearly detectable in the 3H9sdV 8 scid/ 
transgenic controls. To confirm that the LPS/IL4 stimula-
tion resulted in activated B cells, small aliquots of the same
cell cultures analyzed at day 3 were held for 4 d and the cells
were pooled to test for the presence of B220 IgG1  cells.
We found the 3H9sdV 8sd scid and control cell cultures to
contain 10.4 and 15.7% B220 IgG1  cells, respectively
(unpublished data).
 Discussion
Much of the impetus for the present work came from re-
sults of an earlier paper on leaky scid mice (29). Scid mice
are leaky in that productive rearrangements at two critical
loci (e.g., H and L( ) or TCR  and TCR ) occasionally
occur within a given developing scid lymphocyte (for re-
view see reference 47). This leakiness becomes apparent as
scid mice age and results in the generation of pauciclonal B
and T cells and the production of serum Ig. Of particular
interest here is our earlier analysis of sera from 48 leaky scid
mice showed that each mouse expressed two or more IgG
isotypes (IgG1, IgG2a, IgG2b, or IgG3) in addition to IgM.
None of the sera were found to contain IgM only (29) as
might have been expected if IgM–IgG class switching were
severely impaired. Thus, B cells in leaky scid mice showed
no evidence of a severe defect in CSR.
B cells of 3H9sdV 8sd scid mice also showed no evi-
dence of a severe defect in CSR. We found that
3H9sdV 8sd scid mice are able to generate normal levels of
serum IgG and IgA and significant levels of serum IgE
upon reconstitution with T cells. In the absence of T cells,
3H9sdV 8sd scid mice are severely deficient in serum IgG,
IgA, and IgE, even though they contain above normal
numbers of splenic B cells. When 3H9sdVk8sd scid B cells
were stimulated to class switch in vitro, we found that they
Table IV. Lack of DNA-PKcs Activity in scid Pre-B and B Cells
DNA-PKcs
activity 
Cell
line Origin
DNA-PKcs
genotype Exp 1 Exp 2
psl psl
Aa 1B M  /  199; 277 312; 388
2B M  /  353; 229 423; 342
3 BM s/s 239; 344
4 BM s/s 360; 467
5B M  /  2,613; 2,598
6 FL s/s 371; 456
7 FL s/s 441; 319
8F L  /  2,295; 2,012
9 HeLa  /  38,163 36,149
Bb
1B M  /  1,184; 1,103 234; 308
SPL s/s 1,393; 1,553 369; 337
SPL s/  6,826; 6,088 2,489; 3,066
5B M  /  7,099; 7,213 3,520; 3,806
aA-MuLV–transformed scid (s/s) pre-B cell lines were derived from
adult bone marrow (BM) or fetal liver (FL). The relative amount of ki-
nase activity in nuclear extracts of  20   106 cells is expressed in Phos-
phorImager units (psl; Materials and Methods). Pre-B cell lines from
DNA-PKcs /  ( / ) and wt ( / ) mice served as negative and pos-
itive controls, respectively. Analyses for each mouse line were done in
duplicate. Nuclear extract from the human HeLa cell line was included
as a positive control; the values shown correspond to the amount of ki-
nase activity in  20   106 HeLa cells. Exp 1 and Exp 2 represent inde-
pendent experiments.
bSplenic (SPL) cells from 3H9sdV 8sd scid (s/s) mice and sorted B220 
SPL cells from 3H9sdV 8 scid/  (s/ ) mice were stimulated with
LPS/IL4 for 3 d and tested for DNA-PKcs activity. The relative
amount of kinase activity in day 3 nuclear extracts of  20   106 cells is
expressed in phosphorImager units (psl; Materials and Methods). In
both scid and scid/  cell cultures,  86% of the cells were viable at day
3 of culture. Nuclear extract from an equivalent number of bone
marrow (BM) pre-B cells from cell lines 1 and 5 served as negative and
positive controls, respectively. The results for Exp 1 and Exp 2 in B
were obtained independently of those in A. 1491 Bosma et al.
could do so with close to the same efficiency as control
3H9sdV 8 scid/  cells. The implications of our findings
are discussed below.
CSR and V(D)J Recombination Show Differing Dependency
on DNA-PKcs.  Although the results of the present paper
suggest that CSR is no more than two- to threefold less ef-
ficient in scid than wt cells, V(D)J recombination has been
shown to be two to three orders of magnitude less efficient
in scid than wt cells (48, 49). How can this difference be
explained assuming that CSR and V(D)J recombination
both utilize an NHEJ mechanism for joining DNA ends?
One possible explanation is that different kinds of DNA
ends are produced during CSR and V(D)J recombination.
In V(D)J recombination, two kinds of DNA ends are pro-
duced: hairpin coding ends and blunt signal ends (39, 50–
52). Scid cells cannot efficiently resolve hairpin coding ends
(50). Thus, in V(D)J recombination, resolution of hairpin
ends before their joining is one step where DNA-PKcs
plays a critical role. DNA-PKcs also plays an important role
in the processing and joining of open coding ends (53). In
contrast to V(D)J recombination, CSR is RAG indepen-
dent (15, 54) and probably does not involve the generation
of hairpin ends, which is consistent with the detection of
broken DNA with blunt ends following the initiation of
S -S 3 recombination (3). Blunt DNA ends, such as signal
ends, can be joined in both scid (48) and DNA-PKcs–null
cells (28, 55, 56) much more efficiently than coding ends.
Thus, if initiation of CSR often results in blunt DNA ends,
this could explain why CSR is much less dependent on
DNA-PKcs activity than V(D)J recombination. However,
the above reasoning assumes that an NHEJ mechanism is
used exclusively to join DNA ends during CSR. But
whether this is true is unclear as discussed below.
CSR Can Occur in the Absence of DNA-PKcs Activity.
DNA-PKcs activity was not detectable in 3H9sdV 8sd scid
B cells (Table IV). Therefore our finding that class switch-
ing to different IgG isotypes (and IgA) is not severely im-
paired in 3H9sdV 8sd scid B cells suggests that DNA-PKcs
activity is not essential for CSR. However, results from
previous studies imply that DNA-PK plays a critical role in
CSR. These results include the demonstration of defective
CSR in B cells of H/L chain transgenic mice lacking
known components of the NHEJ machinery such as Ku70,
Ku80, and DNA-PKcs (13, 14, 18). There is also evidence
that class switching to IgE is severely impaired in scid pre-B
cell lines (15).
Although we cannot easily reconcile the apparent dis-
crepancy between our results and those of others, we offer
some possible explanations by noting some of the caveats in
the different experimental systems, including our own.
First, as pointed out by others (18), B cells of H/L chain
transgenic mice lacking Ku70 or Ku80 show impaired pro-
liferation and this may account, to a great extent, for the
inability of these cells to class switch. Second, the reported
evidence (18) for severe impairment of CSR in H/L chain
transgenic B cells of mice lacking DNA-PKcs would seem
to apply to all Ig isotypes except IgG1. Class switching to
IgG1 was not impaired in B cells of these mice, whereas
switching to IgG2a, IgG2b, and IgG3 appeared to be se-
verely impaired; the implication being that switching be-
tween   and  1 switch regions is mechanistically different
than switching between   and  2 or  3 switch regions.
This is difficult to understand from a substrate point of
view, given that all   switch regions share 49–52mer re-
peats (19–22). Possibly, the absence of detectable switching
to isotypes other than IgG1 in the H/L chain transgenic B
cells of the DNA-PKcs–null mice reflected a relatively
poor response of these B cells to class switch–inducing
stimuli. For example, the levels of secreted IgG1 observed
in 5-d cultures of appropriately stimulated B cells from
DNA-PKcs–null mice were  100 ng/ml and those of
other isotypes were  10 ng/ml (18). In our work, the lev-
els of IgG1 in 4- to 5-d cultures of LPS/Il4-stimulated B
cells from 3H9sdV 8sd scid mice were in the range of
100–300 ng/ml and those of other IgG isotypes were close
to or greater than 100 ng/ml (Table III and Fig. 7).
Third, early evidence that the scid mutation severely im-
pairs CSR (15) comes from a comparison of class switching
to IgE in scid and wt pre-B cells rather than in B cells, the
cell stage at which CSR normally occurs. In addition, class
switching to IgE may involve more than one recombina-
tion event. Indeed, there is evidence that switching to
IgG1 is often followed by a successive switch to IgE (57,
58). As switching to IgE via IgG1 would represent two
successive recombination events, the overall extent of im-
pairment in class switching to IgE could be much greater
than switching to an upstream IgG constant region gene,
which presumably would involve only one recombination
event. On the basis of our in vivo results, it appears that
class switching to IgE is not severely impaired in scid B
cells. Significant levels of serum IgE were produced in T
cell–reconstituted 3H9sdV 8sd scid mice (Fig. 2). How-
ever, in attempting to assess the relative efficiency with
which scid B cells switch to IgE in vitro, we found that su-
pernatants of LPS/IL4-stimulated scid cell cultures lacked
detectable IgE and that the scid/  controls contained only
very low levels of IgE ( 50 ng/ml). Thus, our results are
uninformative as to the extent to which the scid mutation
impairs switching to IgE.
Finally, scid is not a null mutation (45, 59) and results in a
truncated DNA-PKcs protein lacking DNA-PKcs activity
(16, 17). Thus, it is possible that the defective scid DNA-
PKcs protein, which may be present at normal levels in scid
B lineage cells (16, 17), is recruited by DNA-bound Ku70/
80 and is able to bring DNA ends together despite its lack
of kinase activity (60). In this capacity, the scid DNA-PKcs
may serve as a scaffold for other proteins involved in CSR,
and thereby enable 3H9sdV 8sd scid B cells to class switch
with close to normal efficiency.
NHEJ May Not Be the (Primary or Only) Mechanism for Re-
pair of DNA Breaks Resulting from CSR. Given the pre-
ceding discussion, we are led to question whether a protein
other than DNA-PKcs may associate with DNA-bound
Ku70/80 and provide the necessary kinase activity, or al-
ternatively, whether NHEJ is the (sole) mechanism for
joining DNA ends resulting from CSR. It has been re-1492 Ig Class Switching
ported that DNA lesions associated with the initiation of
CSR are most frequent during the G1 phase of the cell cy-
cle (61), which is consistent with when NHEJ is believed
to occur (62, 63). But whether the observed CSR-associ-
ated DNA lesions in the G1 phase of the cell cycle signify
repair of DNA double strand breaks by NHEJ is open to
question. Repair of such lesions could possibly occur later
and involve a replication-dependent mechanism (64–68) in
which the intermediate products are nicked rather than
fully cleaved DNA molecules. Even if all CSR-associated
DNA nicks were to result in staggered DNA double strand
breaks (4), the repair of these breaks may not necessarily in-
volve NHEJ. This reservation is not only prompted by the
results presented here, but also by results of early studies
showing a high frequency of point mutations, insertions,
and deletions in switch junctions (69, 70). The latter find-
ings led to the proposal of an illegitimate priming model for
CSR (69, 70) whereby DNA double strand breaks, fol-
lowed by exonuclease digestion, result in a single (donor)
strand end that anneals to a microhomologous sequence in
the acceptor switch region. The acceptor switch region se-
quence then serves as a template for priming DNA synthe-
sis. The reciprocal reaction also must occur to complete
switch recombination for both strands of DNA. As pointed
out by others (71, 72), the illegitimate priming model is a
variant of single strand annealing, which can be considered
a form of homologous recombination (7).
Homologous recombination has been postulated as the
mechanism for repair of DNA breaks resulting from initia-
tion of somatic hypermutation (SHM) in Ig variable region
genes (73–76). Interestingly, there is evidence that some
factors may be common to both SHM and CSR. For ex-
ample, a recently discovered enzyme known as activation-
induced cytidine deaminase is essential for both SHM and
CSR (33). Moreover, SHM appears to involve error prone
repair of DNA breaks (for review see reference 77), as orig-
inally postulated by Brenner and Milstein (78), and the
same may be true of CSR, as switch junctions and sur-
rounding regions often contain point mutations (66, 70).
Further, in the absence of the mismatch repair enzyme,
Msh2, the distribution of recombination breakpoints is al-
tered in cells undergoing SHM (or CSR), such that most
breakpoints occur at consensus motifs in the variable (or
switch) regions (79, 80). Finally, both SHM and CSR can
occur in the absence of DNA-PKcs activity (75 and this
study). All of the aforementioned findings are consistent
with some overlap in the machinery responsible for repair
of DNA breaks resulting from initiation of SHM and CSR.
B Cell Anergy in 3H9sdV 8sd Scid Mice Is Broken upon
Reconstitution with T Cells. The 3H9 and V 8 tgs code for
anti-self antibody with specificity for single stranded DNA
and transgenic B cells expressing this specificity (3H9V 8 B
cells) appear to be inactive in the bone marrow at the pre-B
to B transitional stage in nonautoimmune mouse strains
(23, 37, 38). Consistent with such inactivity (anergy), both
3H9sdV 8sd scid mice (this work) and 3H9sdV 8 RAG / 
(37) mice are deficient in serum Ig. Also, 3H9V 8 B cells
show limited ability in vitro to proliferate and secrete Ig in
response to low doses of LPS ( 10  g/ml) or anti-IgM
Fab(ab) 2 ( 50  g/ml) compared with nontransgenic B
cells (23, 38). Significant proliferation of 3H9/V 8 B cells
does occur, however, when these cells are stimulated with
high doses of LPS (10–20  g/ml) or anti-IgM (50  g/ml;
reference 37) or when their surface IgM is cross-linked in
the presence of T cell help (38). Indeed, our results (Table
III) suggest that B cells from 3H9sdV 8sd scid and
3H9sdV 8 scid/  mice proliferate as well as (or better
than) B cells from nontransgenic scid/  mice in response
to high doses of LPS (50  g/ml) and IL4.
Thus, the ability of 3H9V 8 B cells to proliferate or re-
spond to differentiation stimuli may depend on the strength
of the stimuli and the microenvironment in which these
cells arise. For example, as reported earlier (37), 3H9V 8 B
cells that develop in the absence of T cells, as in 3H9sdV 8
RAG /  mice, may be partially activated. Two distinct
populations of B cells were found in 3H9sdV 8 RAG / 
mice: one lacked surface CD43 and expressed low IgM and
high IgD (CD43-IgMlo IgDhi), the other expressed high
CD43, high IgM, and low IgD (CD43hiIgMhi IgDlo), a
phenotype associated with activated B cells (81). The latter
cell population was not found in 3H9sdV 8 RAG /  mice
(37). Full activation of the CD43hiIgMhi IgDlo B cell popu-
lation may result if these B cells are provided T cell help.
As shown here, when 3H9sdV 8sd scid mice were pro-
vided with a source of T cells from JH /  donors, the re-
cipients generated T cells (Fig. 1 B) and expressed normal
levels of serum IgG and IgA (Fig. 2). Moreover, all of the
recipients expressed IgG1 and IgG2a of the tg allotype (un-
published data). What might be the mechanism for this ap-
parent breakage in B cell tolerance? One possibility is that
IgM-expressing B cells in the 3H9sdV 8sd scid recipients
serve as antigen-presenting cells for naive, autoreactive T
cells from the JH /  donor mice, and in turn, are T cell–
activated to undergo IgM–IgG class switching. Regardless
of the mechanism, it is clear that 3H9sdV 8sd scid mice
contain B cells that can be fully activated to undergo CSR
in the presence of T cells and (self?) antigen.
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